Skip to main content
. 2018 Feb 8;9(17):13682–13693. doi: 10.18632/oncotarget.24455

Figure 2. PD-L1 expression in NSCLC using immunohistochemistry using SP147 PD-L1 clone.

Figure 2

The tumor proportion score (TPS) is shown.